• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高温度:新疫苗儿童计划(VFC)推荐使用温度监测器对不正确产品储存不良事件报告的影响。

Turning up the heat: Effect of new vaccine for children's (VFC) program recommendations for use of temperature monitors upon incorrect product storage adverse event reporting.

机构信息

Merck & Co., Inc., Kenilworth, NJ, USA.

Merck & Co., Inc., Kenilworth, NJ, USA.

出版信息

Vaccine. 2018 Mar 7;36(11):1516-1520. doi: 10.1016/j.vaccine.2017.10.059.

DOI:10.1016/j.vaccine.2017.10.059
PMID:29429809
Abstract

BACKGROUND

The Centers for Disease Control and Prevention (CDC) coordinates the Vaccines For Children (VFC) program, which provides free vaccines to qualified children in the US. In 2009, the CDC issued Vaccine Storage Requirements, which were later replaced (2012) with an interim guidance and toolkit for vaccine storage and handling. The guidance called for use of Digital Data Loggers (DDL) to monitor vaccine storage temperatures. We describe a change in frequency of Incorrect Product Storage Reports (IPSRs) following issuance of the 2009 CDC guidance.

METHODS

Merck & Co., Inc., Kenilworth, NJ, USA, systematically evaluates vaccine safety concerns for all products. The safety database was queried (01-Jan-2004 through 31-December-2016) to identify all IPSRs associated with 10 vaccines. We compared IPSRs received prior to and following the 2009 CDC guidance, comparing reports received from the US with those received from international sources during the same period.

RESULTS

Following the release of the DDL guidance, a progressive increase in IPSRs was identified in the US (1 report received in 2004, 12,993 reports in 2016). In contrast, non-US IPSRs - have not had a similar increase: no reports received in 2004, 216 reports received in 2016. US reports of IPSRs 2004 through 2016 account for 96% of reports worldwide. There were no serious reports found in the database in conjunction with IPSRs, nor were there any additional safety findings in any of the reports with additional events reported.

CONCLUSION

VFC DDL guidance was followed by an increase in IPSRs. No similar trend was seen outside the US (where no broad change in DDL guidance occurred). Despite the increase in IPSRs, there have been few associated adverse events (AEs) reported; no new safety concerns were identified. These findings suggest that the increase in IPSRs was associated with the introduction of use of DDLs, and suggests the need for further impact assessment.

摘要

背景

疾病控制与预防中心(CDC)协调疫苗接种儿童(VFC)计划,为美国合格儿童提供免费疫苗。2009 年,CDC 发布了疫苗储存要求,随后(2012 年)被一份临时指南和疫苗储存及处理工具包所取代。该指南呼吁使用数字数据记录器(DDL)监测疫苗储存温度。我们描述了在 2009 年 CDC 指南发布后,不正确产品储存报告(IPSR)的频率发生了变化。

方法

默克公司,新泽西州肯尼沃斯,美国,系统地评估所有产品的疫苗安全问题。安全数据库被查询(2004 年 1 月 1 日至 2016 年 12 月 31 日),以确定与 10 种疫苗相关的所有 IPSR。我们比较了 2009 年 CDC 指南发布前后收到的 IPSR,比较了同期从美国和国际来源收到的报告。

结果

DDL 指南发布后,美国的 IPSR 逐渐增加(2004 年收到 1 份报告,2016 年收到 12993 份报告)。相比之下,非美国的 IPSR 没有类似的增加:2004 年没有收到报告,2016 年收到 216 份报告。2004 年至 2016 年,美国 IPSR 报告占全球报告的 96%。数据库中未发现与 IPSR 相关的严重报告,也未在任何报告中发现任何额外的安全发现。

结论

VFC DDL 指南发布后,IPSR 增加。在美国以外地区没有看到类似的趋势(没有广泛的 DDL 指南变化)。尽管 IPSR 增加了,但报告的不良事件(AE)很少;没有发现新的安全问题。这些发现表明,IPSR 的增加与 DDL 的使用有关,并表明需要进一步进行影响评估。

相似文献

1
Turning up the heat: Effect of new vaccine for children's (VFC) program recommendations for use of temperature monitors upon incorrect product storage adverse event reporting.提高温度:新疫苗儿童计划(VFC)推荐使用温度监测器对不正确产品储存不良事件报告的影响。
Vaccine. 2018 Mar 7;36(11):1516-1520. doi: 10.1016/j.vaccine.2017.10.059.
2
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.免疫接种后安全性监测:疫苗不良事件报告系统(VAERS)——美国,1991 - 2001年
MMWR Surveill Summ. 2003 Jan 24;52(1):1-24.
3
Vaccination errors reported to the Vaccine Adverse Event Reporting System, (VAERS) United States, 2000-2013.2000年至2013年向美国疫苗不良事件报告系统(VAERS)报告的疫苗接种错误。
Vaccine. 2015 Jun 22;33(28):3171-8. doi: 10.1016/j.vaccine.2015.05.006. Epub 2015 May 14.
4
Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).在事件前疫苗接种计划中使用天花疫苗的建议。免疫实践咨询委员会(ACIP)和医疗保健感染控制实践咨询委员会(HICPAC)的补充建议。
MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16.
5
Preparation for global introduction of inactivated poliovirus vaccine: safety evidence from the US Vaccine Adverse Event Reporting System, 2000-12.为全球引入灭活脊髓灰质炎病毒疫苗做准备:来自美国疫苗不良事件报告系统的安全性证据,2000-2012 年。
Lancet Infect Dis. 2015 Oct;15(10):1175-1182. doi: 10.1016/S1473-3099(15)00059-6. Epub 2015 Aug 16.
6
General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP).一般预防接种建议——免疫实施咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2011 Jan 28;60(2):1-64.
7
Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.2005-2015 年美国疫苗不良事件报告系统(VAERS)中已获许可的乙型肝炎表面抗原疫苗的安全性。
Vaccine. 2018 Jan 25;36(4):559-564. doi: 10.1016/j.vaccine.2017.11.079. Epub 2017 Dec 11.
8
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.评估疫苗上市后安全性面临的挑战:来自疾病预防控制中心的观察。
Expert Rev Vaccines. 2019 Oct;18(10):1091-1101. doi: 10.1080/14760584.2019.1676154. Epub 2019 Oct 19.
9
Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008-2012.疫苗在推荐温度之外的安全性:疫苗不良事件报告系统(VAERS)报告,2008-2012 年。
Vaccine. 2018 Jan 25;36(4):553-558. doi: 10.1016/j.vaccine.2017.11.083. Epub 2017 Dec 14.
10
Preventable mix-ups of tuberculin and vaccines: reports to the US Vaccine and Drug Safety Reporting Systems.结核菌素与疫苗可预防的混淆:向美国疫苗与药品安全报告系统提交的报告
Drug Saf. 2008;31(11):1027-33. doi: 10.2165/00002018-200831110-00007.

引用本文的文献

1
Sedimentation behavior of quality and freeze-damaged aluminum-adjuvanted vaccines by NMR.通过 NMR 研究质量和冷冻损伤的含铝佐剂疫苗的沉淀行为。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2215152. doi: 10.1080/21645515.2023.2215152.
2
All vials are not the same: Potential role of vaccine quality in vaccine adverse reactions.并非所有疫苗瓶都一样:疫苗质量在疫苗不良反应中的潜在作用。
Vaccine. 2021 Oct 29;39(45):6565-6569. doi: 10.1016/j.vaccine.2021.09.065. Epub 2021 Oct 6.
3
Grand Challenges in Pharmaceutical Research Series: Ridding the Cold Chain for Biologics.
医药研发领域的重大挑战系列:摆脱生物制剂冷链的束缚。
Pharm Res. 2021 Jan;38(1):3-7. doi: 10.1007/s11095-021-03008-w. Epub 2021 Feb 8.
4
Effect of thermal ballast loading on temperature stability of domestic refrigerators used for vaccine storage.家用冰箱热负荷对疫苗存储温度稳定性的影响。
PLoS One. 2020 Jul 8;15(7):e0235777. doi: 10.1371/journal.pone.0235777. eCollection 2020.
5
Investigating safety profiles of human papillomavirus vaccine across group differences using VAERS data and MedDRA.利用疫苗不良事件报告系统(VAERS)数据和国际医学用语词典(MedDRA)调查人乳头瘤病毒疫苗在不同群体间的安全性概况。
PeerJ. 2019 Aug 20;7:e7490. doi: 10.7717/peerj.7490. eCollection 2019.